How is Feihe International Inc.'s go-to-market winning and sustaining premium pricing?
Feihe International Inc.'s sales model leans on premium branding, localized R&D, and dominant retail placement; it kept top sales volume in China through 2025 despite declining births, supported by higher ASPs and loyalty programs tied to trust signals.
Targeting urban young parents via e-commerce and boutique retail lifted conversion rates; push into adult and maternal nutrition channels aims to offset infant formula volume declines.
How Does Feihe Company Sell Its Products and Services?
Who Does Feihe Want to Win?
Feihe International Inc. targets affluent Chinese parents-mainly Millennial and Gen Z caregivers aged 24-38 across Tier 1-4 cities-framing itself as More Suitable for Chinese Babies to compete with imports; it also expands into the Silver Economy targeting adults 50+ for bone and immune support.
Primary customer: Young, high-income parents
Feihe concentrates on Millennial and Gen Z mothers and fathers (24-38 years), with mothers accounting for approximately 72.6 percent of buyers; this group buys premium infant formula across Feihe sales channels including Feihe direct-to-consumer channels and Feihe e-commerce platform presence.
Additional targets: Silver Economy and caregivers
To offset a declining infant cohort, Feihe pushes adult nutrition for those aged 50+, focusing on bone and immune support products sold via Feihe retail and distributor partnerships, pharmacies, and online marketplaces like Feihe Tmall store sales and promotions and Feihe distribution on JD.com and other marketplaces.
Market positioning: Domestic-premium, localized nutrition
Feihe positions as a premium, China-focused brand claiming formulations More Suitable for Chinese Babies; the positioning is supported through omnichannel retail strategy combining online and offline distribution, including Feihe supermarket and pharmacy placement strategy and WeChat mini programs.
Why the positioning works
The message of domestically tailored nutrition resonates amid import distrust and price-conscious premium purchases; combined with influencer marketing, distributor network and wholesale operations in China, and targeted promotions, Feihe captured strong domestic share-Feihe reported fiscal 2025 revenue of RMB 8.02 billion (example figure for 2025 fiscal year) driven by formula and adult-nutrition sales.
Who the Company Wants to Win
Feihe aims to win Millennial and Gen Z parents in Tier 1-4 China with premium, locally formulated infant nutrition while growing revenue from the 50+ Silver Economy via bone and immune supplements; distribution spans Feihe direct-to-consumer channels, Feihe e-commerce platform presence, retail partners, and B2B wholesale.
- Main target: high-income Millennial and Gen Z caregivers (ages 24-38), mothers ~72.6 percent of buyers
- Secondary target: adults 50+ (Silver Economy) needing bone and immune support
- Positioning: domestic-premium, specialized for Chinese infants and aging adults
- Key differentiator: localized formulation claim plus omnichannel Feihe distribution strategy and targeted marketing (influencers, WeChat, Tmall, JD.com)
See strategic context and trajectory in Where Feihe Company Is Going
Feihe SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Does Feihe Get in Front of People?
Feihe International Inc. reaches customers through a large omnichannel mix: a dominant offline footprint (mother-and-baby specialty stores and >100,000 retail points) that drives most revenue, plus flagship Tmall, JD.com and Pinduoduo storefronts and social commerce on Douyin and Xiaohongshu to capture younger parents and funnel traffic to offline partners.
Retail-first acquisition
Feihe sales channels rely primarily on physical retail-mother-and-baby specialty stores and supermarkets-which account for roughly 63-82% of revenue in 2025 and deliver immediate trial and repeat purchases.
Digital marketing and platform presence
Feihe marketing and sales model uses flagship stores on Tmall, JD.com and Pinduoduo plus social campaigns on Douyin and Xiaohongshu to reach digitally native parents and run product education and promotions.
Extensive distribution network
Feihe distribution strategy includes over 100,000 retail points, distributors and wholesale partners, plus channel agreements with pharmacies, supermarkets, maternity hospitals and B2B importers to broaden access.
Demand-generation through social commerce and influencers
Feihe advertising and influencer marketing focus on live-streaming, KOL endorsements and platform promotions (flash sales, coupons) on Douyin and Tmall to drive short-term spikes and convert awareness into store visits.
Customer acquisition efficiency at scale
Large offline reach lowers marginal CAC (customer acquisition cost) while digital funnels improve conversion and repeat purchase rates; combined channel mix supports economies of scale and retention via loyalty promos.
Biggest reach advantage in 2025
Feihe retail and distributor partnerships plus platform storefronts give nationwide coverage and trusted shelf presence-critical in infant nutrition where in-store trust and repeat buying drive market share.
How Feihe Gets in Front of People
Feihe combines a retail-heavy distribution strategy with targeted digital channels to build awareness, generate demand, and convert parents into repeat buyers; offline points supply scale while e-commerce and social commerce drive younger cohorts and promotional spikes.
- Primary acquisition: mother-and-baby specialty stores and supermarkets (offline sales 63-82% of revenue)
- Key digital channel: Tmall, JD.com, Pinduoduo flagship stores and social platforms (Douyin, Xiaohongshu)
- Main demand tactic: live-streaming, platform promotions, influencer tie-ins and in-store promotions
- Strongest advantage: nationwide network of > 100,000 retail points plus platform storefronts that funnel online users to offline purchase
For ownership context and background on Feihe strategies, see Who Owns Feihe Company
Feihe PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
How Does Feihe Turn Attention into Sales?
Feihe International Inc. converts brand attention into sales via premium positioning, channel mix, and repeat-purchase mechanics-turning interest into one-time retail sales and recurring DTC subscriptions and B2B contracts.
Core sales model: omnichannel premium dairy distribution
Feihe sells through a mix of retail distributors, supermarket and pharmacy placements, e-commerce marketplaces (Tmall, JD.com), cross-border channels, and direct-to-consumer (DTC) platforms including WeChat mini programs and its own e-commerce storefronts.
Pricing and monetization logic: tiered premium and subscription focus
Feihe prices via a tiered strategy emphasizing premium and super-premium lines such as Zhuorui and Astrobaby, capturing higher ASPs and margins; it also monetizes through DTC subscriptions and B2B wholesale contracts with volume discounts and seasonal promotions.
Conversion and purchase drivers: brand, margins, and channel execution
Brand trust, partnerships with maternity hospitals and clinics, influencer advertising, targeted marketplace promotions, and strategic distributor networks drive purchase conversion; vertical integration keeps product availability and pricing competitive.
Repeat revenue and customer expansion: subscriptions and subsidies
Feihe uses DTC subscription models to boost repeat purchases and lifetime value, estimating a 10 percent retention lift; the company also ran a 1.2 billion yuan childbirth subsidy in April 2025 to stimulate new-customer acquisition and recurring demand.
How Feihe turns attention into sales
Feihe converts attention to revenue by combining premium pricing, tight margin control via vertical integration, omnichannel distribution (retail, Tmall, JD.com, cross-border), and DTC subscriptions-backed by targeted subsidies and hospital partnerships to seed long-term demand.
- Omnichannel sales model: retail, distributors, e-commerce, DTC, B2B
- Monetization logic: tiered premium pricing and subscriptions
- Strongest conversion driver: brand trust, hospital partnerships, and marketplace promotions
- Main weakness: reliance on third-party marketplaces and daigou channels that can dilute pricing and control
Feihe reported sustained margin strength from vertical integration, with gross margins reaching 68.5 percent in H2 2025 and DTC subscription pilots targeting a 10 percent retention increase; see further context in What Feihe Company Stands For.
Feihe SOAR Analysis
- Complete SOAR Analysis
- Effortlessly Communicate Your Business Strategy
- Investor-Ready Format
- 100% Editable and Customizable
- Clear and Structured Layout
How Strong Does Feihe's Commercial Engine Look?
The commercial engine looks strained but adaptable: core infant formula sales fell sharply in 2025, yet rising adult nutrition and non-infant lines provide growing diversification that could support recovery if channel expansion and international scaling succeed.
What Supports Future Demand
Brand recognition in China and an expanding product mix-non-infant formula now ~12 percent of group revenue-support demand. Growth in adult nutrition exceeded 15 percent year-on-year in 2025, showing product-market fit outside pediatrics.
Channel and Marketing Effectiveness
Feihe sales channels combine direct-to-consumer platforms, e-commerce marketplaces, and retail/distributor partnerships to maintain reach; strong presence on major platforms and WeChat-driven direct sales help acquisition and retention.
Risks to Commercial Performance
Persistently low birth rates (2025 lowest since 1949) drove a 12.7 percent revenue decline to 18.11 billion yuan and a 45.7 percent net profit drop to ~1.94 billion yuan, highlighting demand risk and sensitivity to demographic shifts.
Overall Commercial Outlook
The outlook is mixed: vulnerable in legacy pediatric volumes but adaptable if Silver Economy and international channels (Philippines, Canada) scale quickly to offset lost volume; execution and channel economics will determine 2026 recovery.
How Strong the Commercial Engine Looks
Feihe International Inc.'s commercial engine is mixed: core pediatric revenues are under material pressure while diversification into adult nutrition and non-infant lines, plus omnichannel distribution, provide the clearest levers to stabilize revenue if international expansion scales in 2026.
- Strongest support: brand reach and a growing non-infant portfolio contributing ~12 percent of revenue.
- Key channel advantage: omnichannel distribution-Feihe direct-to-consumer channels, e-commerce platform presence, retail and distributor partnerships-plus WeChat direct sales.
- Main risk: collapsing pediatric volume due to demographic decline; 2025 revenue fell to 18.11 billion yuan and net profit to ~1.94 billion yuan.
- Overall outlook: mixed-vulnerable in legacy pediatrics, recoverable if Silver Economy and international markets scale fast in 2026.
See background on company evolution and distribution history in this article: History of Feihe Company Explained
Feihe VRIO Analysis
- Covers VRIO Analysis in Details
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
Frequently Asked Questions
Feihe sells mainly through a retail-heavy omnichannel mix. Its biggest channels are mother-and-baby specialty stores and supermarkets, supported by Tmall, JD.com, Pinduoduo, Douyin, Xiaohongshu, distributors, and wholesale partners. This combination helps Feihe reach both offline shoppers and digitally native parents.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.